Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:

Schedule

*Product:*	Abilify Maintena
Active Ingredient:	Aripiprazole monohydrate 312.05mg equivalent to aripiprazole 300mg
Dosage Form:	Powder for injection
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:	Otsuka Pharmaceutical Co Limited, Tokushima, Japan

*Product:*	Abilify Maintena
Active Ingredient:	Aripiprazole monohydrate 416.07mg equivalent to aripiprazole 400mg
Dosage Form:	Powder for injection
New Zealand Sponsor:	Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturers:	Otsuka Pharmaceutical Co Limited, Tokushima, Japan

Dated this 12th day of May 2025.

CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Schedule